Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xenotransplantation: is this the future?

W W Hancock1

  • 1Department of Pathology, Harvard Medical School, Boston, MA, USA.

Seminars in Nephrology
|April 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, London, Ont., Sept. 19 to 22, 2002.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Editorial: Mechanisms guarding the genome.

Frontiers in cell and developmental biology·2022
Same author

Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Same author

Class-specific histone/protein deacetylase inhibition protects against renal ischemia reperfusion injury and fibrosis formation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers.

Clinical and experimental immunology·2014
Same author

Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3+ T-regulatory cells.

Mucosal immunology·2014
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
Same journal

The Role of the Epidermal Growth Factor Receptor in Kidney Tubulointerstitial Fibrosis.

Seminars in nephrology·2026
See all related articles

Xenotransplantation, using genetically modified pigs for human transplants, is experimental after 5 years. Clinical use is likely a decade away, but research offers unexpected medical benefits.

Area of Science:

  • Transplantation immunology
  • Medical research

Background:

  • Xenotransplantation, the use of animal organs or tissues in humans, has advanced significantly with genetically modified pigs.
  • Despite over five years of research, xenotransplantation remains largely experimental and faces considerable controversy.

Purpose of the Study:

  • To review the current status of xenotransplantation, focusing on challenges and potential.
  • To assess the timeline for clinical application and the broader impact of ongoing research.

Main Methods:

  • Review of the scientific literature and clinical research in xenotransplantation.
  • Analysis of immunologic barriers, infectious risks, and biocompatibility issues.

Main Results:

  • Significant immunologic barriers, including delayed xenograft rejection, persist.

Related Experiment Videos

  • Infectious risks and biocompatibility challenges require further investigation and mitigation strategies.
  • Robust clinical application of xenotransplantation is estimated to be at least a decade away.

    • Conclusions:

    • Xenotransplantation research, while not yet clinically ready, is yielding valuable insights applicable to other medical fields.
    • Continued investigation into overcoming immunologic and biological hurdles is crucial for future success.